Диссертация (1140688), страница 15
Текст из файла (страница 15)
- 2012;109(8):1198-206.144.Tiselius H.G.Stones: Guidelines reignite interest in medicaltreatment of stones. /Tiselius H.G. // Nat. Rev. Urol. - 2014;11(9):490-492.145.Trends in urological stone disease. / Turney B.W., Reynard J.M.,Noble J.G., Keoghane S.R. // BJU International - 2012;109(7):1082–1087.146.Urinary tract infection in patients with chronic kidney disease.
/ HsiaoC.Y., Lin H.L., Lin Y.K., Chen C.W., Cheng Y.C., Lee W.C. // TurkishJournal of Medical Sciences - 2014;44:145-149147.Use of the national health and nutrition examination survey tocalculate the impact of obesity and diabetes on cost and prevalence ofurolithiasis in 2030 /Antonelli J.A., Maalouf N.M., Pearle M. S., Lotan Y. //European Urology. – 2014;66(4):724–729.148.Wild S. Global prevalence of diabetes: estimates for the year 2000 andprogections for 2030.
/ Wild S., Rolgloc G., Green A. // Diabet Care. – 200427:1047-1053.110149.Wong Y.V. The Association of Metabolic Syndrome and Urolithiasis./Wong Y.V., Cook P., Somani B.K.// International Journal of Endocrinology- 2015; 2: 5706-5715150.Worcester E.M. Nephrolithiasis. / Worcester E.M., Coe F.L. // PrimCare. - 2008;35:369–91.151.Xu H. Kidney stones: an update on current pharmacologicalmanagement and future directions.
/Xu H., Zisman A.L., Coe F.L.,Worcester E.M. // Expert Opin Pharmacother - 2013;14(4):435-47..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
